Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus-Importance of dominant and subdominant epitopes for antigenicity and protection

Vaccine

Volumn 25, Issue 33, 2007, Pages 6191-6200

  Frimann, Tine Holland ^a,b   Barfoed, Annette Malene ^a   Aasted, Bent ^b   Kamstrup, Søren ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

B cell epitopes; Cross reactivity; FMDV; Foot and mouth disease; Protection

Indexed keywords

CAPSID PROTEIN; EPITOPE; FOOT AND MOUTH DISEASE VACCINE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, VIRAL; CAPSID PROTEINS; EPITOPES, B-LYMPHOCYTE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNODOMINANT EPITOPES; MICE; PLASMIDS; VACCINES, DNA; VIRAL VACCINES; VIREMIA;

EID: 34447629534     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.002     Document Type: Article

References (32)

1. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., et al. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2 2 (1994) 123-139
2. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., and Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337 6209 (1989) 709-716
3. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., et al. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4 2 (1996) 135-145
4. Dunn C.S., Samuel A.R., Pullen L.A., and Anderson J. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 247 1 (1998) 51-61
5. McCahon D., Crowther J.R., Belsham G.J., Kitson J.D., Duchesne M., Have P., et al. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol 70 Pt 3 (1989) 639-645
6. Bolwell C., Clarke B.E., Parry N.R., Ouldridge E.J., Brown F., and Rowlands D.J. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J Gen Virol 70 Pt 1 (1989) 59-68
7. Xie Q.C., McCahon D., Crowther J.R., Belsham G.J., and McCullough K.C. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68 Pt 6 (1987) 1637-1647
8. Crowther J.R., Farias S., Carpenter W.C., and Samuel A.R. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74 Pt 8 (1993) 1547-1553
9. Feigelstock D.A., Mateu M.G., Valero M.L., Andreu D., Domingo E., and Palma E.L. Emerging foot-and-mouth disease virus variants with antigenically critical amino acid substitutions predicted by model studies using reference viruses. Vaccine 14 2 (1996) 97-102
10. Mateu M.G., Camarero J.A., Giralt E., Andreu D., and Domingo E. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206 1 (1995) 298-306
11. Hopp T.P., and Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78 6 (1981) 3824-3828
12. Kamstrup S., Barfoed A.M., Frimann T.H., Ladekjaer-Mikkelsen A.S., and Botner A. Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 22 11/12 (2004) 1358-1361
13. Sobrino F., Davila M., Ortin J., and Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128 2 (1983) 310-318
14. Kamstrup S., Frimann T.H., and Barfoed A.M. Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides. Antiviral Res (2006)
15. Have P., Lei J.C., and Schjerning-Thiesen K. An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot-and-mouth disease. Characterization and comparison with complement fixation. Acta Vet Scand 25 2 (1984) 280-296
16. Rieder E., Baxt B., Lubroth J., and Mason P.W. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J Virol 68 11 (1994) 7092-7098
17. Carrillo C., Tulman E.R., Delhon G., Lu Z., Carreno A., Vagnozzi A., et al. Comparative genomics of foot-and-mouth disease virus. J Virol 79 10 (2005) 6487-6504
18. Rossmann M.G., and Palmenberg A.C. Conservation of the putative receptor attachment site in picornaviruses. Virology 164 2 (1988) 373-382
19. Haydon D.T., and Woolhouse M.E. Immune avoidance strategies in RNA viruses: fitness continuums arising from trade-offs between immunogenicity and antigenic variability. J Theor Biol 193 4 (1998) 601-612
20. Feng Q., Yu H., Liu Y., He C., Hu J., Sang H., et al. Genome comparison of a novel foot-and-mouth disease virus with other FMDV strains. Biochem Biophys Res Commun 323 1 (2004) 254-263
21. Pfaff E., Mussgay M., Bohm H.O., Schulz G.E., and Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J 1 7 (1982) 869-874
22. Fischer D., Rood D., Barrette R.W., Zuwallack A., Kramer E., Brown F., et al. Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge. J Virol 77 13 (2003) 7486-7491
23. McCullough K.C., Crowther J.R., Carpenter W.C., Brocchi E., Capucci L., De Simone F., et al. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology 157 2 (1987) 516-525
24. Baxt B., Vakharia V., Moore D.M., Franke A.J., and Morgan D.O. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 63 5 (1989) 2143-2151
25. Oem J.K., Lee K.N., Cho I.S., Kye S.J., Park J.Y., Park J.H., et al. Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea. J Vet Sci 6 2 (2005) 117-124
26. Mateu M.G., Hernandez J., Martinez M.A., Feigelstock D., Lea S., Perez J.J., et al. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 68 3 (1994) 1407-1417
27. Scheerlinck J.P., DeLeys R., Saman E., Brys L., Geldhof A., and De Baetselier P. Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein. Mol Immunol 30 8 (1993) 733-739
28. Beard C., Ward G., Rieder E., Chinsangaram J., Grubman M.J., and Mason P.W. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J Biotechnol 73 2/3 (1999) 243-249
29. Chinsangaram J., Beard C., Mason P.W., Zellner M.K., Ward G., and Grubman M.J. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 72 5 (1998) 4454-4457
30. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., and Kihm U. Protective immune response against foot-and-mouth disease. J Virol 66 4 (1992) 1835-1840
31. McCullough K.C., Crowther J.R., Butcher R.N., Carpenter W.C., Brocchi E., Capucci L., et al. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology 58 3 (1986) 421-428
32. McCullough K.C., Parkinson D., and Crowther J.R. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65 2 (1988) 187-191